2019 surveillance update
Update in progress: Drug therapy (excluding insulin-based treatments): see the December 2024 guideline update page.
Portfolio review in May 2023: We have reviewed our guidelines portfolio to identify topics that we think will add the most value to the health and care system and have agreed the update on insulin therapy recommended in this surveillance report will not proceed as planned.
This page was last updated: